Personalizing Treatment From Start to Finish in Polycythemia Vera

The landscape for the diagnosis and treatment of polycythemia vera is changing to include more refined criteria for diagnosing symptomatic patients and identifying those at highest risk.


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.